ShockWave Medical stock is trading -17.79% below its average target price of $284.89 after marking a 5.2% during today's evening session. Analysts are giving the mid-cap Medical Instruments & Supplies company an average rating of buy and target prices ranging from $165.0 to $330.0 per share.
The stock has an average amount of shares sold short at 3.9%, and a short ratio of 1.94. Since 1.18% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 93.3% of ShockWave Medical's shares being owned by this investor type.
Institutions Invested in ShockWave Medical
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-06-30 | Blackrock Inc. | 10% | 3,636,444 | $851,727,918 |
| 2023-06-30 | Vanguard Group Inc | 10% | 3,603,014 | $843,897,943 |
| 2023-06-30 | FMR, LLC | 7% | 2,434,974 | $570,319,613 |
| 2023-06-30 | Wellington Management Group, LLP | 4% | 1,352,723 | $316,834,782 |
| 2023-06-30 | Artisan Partners Limited Partnership | 3% | 1,147,784 | $268,833,969 |
| 2023-06-30 | Price (T.Rowe) Associates Inc | 3% | 1,091,050 | $255,545,732 |
| 2023-06-30 | State Street Corporation | 3% | 1,018,186 | $238,479,526 |
| 2023-06-30 | JP Morgan Chase & Company | 2% | 835,138 | $195,606,023 |
| 2023-06-30 | Invesco Ltd. | 2% | 773,776 | $181,233,815 |
| 2023-06-30 | Capital World Investors | 2% | 585,000 | $137,018,700 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on ShockWave Medical.
